DC1 (Qinlock 50 mg)
Generic Name: ripretinib
Pill with imprint DC1 is White, Elliptical / Oval and has been identified as Qinlock 50 mg. It is supplied by Deciphera Pharmaceuticals, Inc..
Qinlock is used in the treatment of gastrointestinal stromal tumor and belongs to the drug class multikinase inhibitors. Qinlock 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DC1
Qinlock
- Generic Name
- ripretinib
- Imprint
- DC1
- Strength
- 50 mg
- Color
- White
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Deciphera Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 73207-0101
Related Images for "DC1"
More about Qinlock (ripretinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.